Drug profile · INN
tamoxifen citrate
TAMOXIFEN CITRATE
tamoxifen citrate (TAMOXIFEN CITRATE) is a estrogen receptor alpha modulator. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — tamoxifen citrate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 4
- Data quality
- 0.89
Quick answer
tamoxifen citrate (TAMOXIFEN CITRATE) is a estrogen receptor alpha modulator. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Estrogen receptor alpha modulator
Primary target: Estrogen receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is tamoxifen citrate?
tamoxifen citrate (TAMOXIFEN CITRATE) is a estrogen receptor alpha modulator. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tamoxifen citrate?
TAMOXIFEN CITRATE is a marketed brand name for tamoxifen citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tamoxifen citrate?
tamoxifen citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.